Abstract:Abstract Background: We have previously developed a prevascularized platform by seeding endothelial cells on the mesenchymal stem cell sheet and the technology provides a promising vascularization potential for wide applications in tissue engineering. However, the mechanism behind the interactions between stem cell sheet-derived matrix and endothelial cells (ECs) are still unknown. The purpose of this study is to investigate the role of MMPs in angiogenesis process in vitro.Methods: Human bone marrow-derived mesenchymal stem cells (hBMSCs) were cultured continually to form a thin cell sheet, and then green fluorescent protein (GFP)-labeled human umbilical vein endothelial cells (HUVECs) were seeded on the cell sheet to form a prevascularized system. Fibronectin, collagen I and MMPs immunofluorescence staining were used to observe their interaction changes. After that, HUVECs and hBMSCs were sorted by flow cytometry and RT-PCR was performed to quantify related gene expression of ECs and stem cells. In order to further explore the possible mechanism, the broad-spectrum MMPs inhibitor GM6001 was added into the medium to observe the effects of vascular network formation. Results: The immunofluorescence staining results showed that HUVECs secreted MMP-2 and membrane-type matrix metalloproteinase-1 (MT1-MMP) in the early stage of angiogenesis. MMPs degraded and remodeled the ECM to create space for vascular formation. HUVECs also promoted hBMSCs to secrete tissue inhibitors of metalloproteinase-2 (TIMP-2), which can stabilize blood vessels by avoiding excessive vascularization or vascular degradation in the later stage. Thus, HUVECs/hBMSCs co-culture group were beneficial for angiogenesis than the other two control groups. With the addition of the broad-spectrum matrix metalloproteinase inhibitor GM6001, RT-PCR results showed that the formation of EC lumen was blocked, while the mean fluorescence density of fibronectin and collagen I were increased.Conclusions: our study suggests that the MMP-2, MT1-MMP and TIMP-2 can synergistically regulate the angiogenesis. In addition, HUVECs and hBMSCs interact with each other in the process of vascular formation, and jointly regulate and promote the construction of lumen. These results also indicate a promising potential using the hBMSCs sheet as a platform for broad applications in engineering vascularized tissues.

Gap Junction-Mediated MiR-200b on Osteogenesis and Angiogenesis in Coculture Between MSCs and HUVECs

Inhibiting expression of Cxcl9 promotes angiogenesis in MSCs-HUVECs co-culture.

Fabrication of viable and functional pre-vascularized modular bone tissues by coculturing MSCs and HUVECs on microcarriers in spinner flasks.

Regulation of Matrix Metalloproteinase in Vascularization of Endothelial Cells on Extracellular Matrix Secreted by Mesenchymal Stem Cell Sheet

The promotion of bone regeneration through positive regulation of angiogenic-osteogenic coupling using microRNA-26a

MicroRNA-378 Promotes Osteogenesis-Angiogenesis Coupling in BMMSCs for Potential Bone Regeneration

Endothelialized microvessels fabricated by microfluidics facilitate osteogenic differentiation and promote bone repair

Tension-loaded Bone Marrow Stromal Cells Potentiate the Paracrine Osteogenic Signaling of Co-Cultured Vascular Endothelial Cells

Exosomal miR-423-5p Derived from Mineralized Osteoblasts Promotes Angiogenesis of Endothelial Cells by Targeting CXCL10

Efficiency of coculture with angiogenic cells or physiological BMP-2 administration on improving osteogenic differentiation and bone formation of MSCs

Mechanosensitive Mir-99B Mediates the Regulatory Effect of Matrix Stiffness on Bone Marrow Mesenchymal Stem Cell Fate Both in Vitro and in Vivo.

Hypoxia Alleviates Dexamethasone-Induced Inhibition of Angiogenesis in Cocultures of HUVECs and Rbmscs Via HIF-1α

Co-cultivation of Progenitor Cells Enhanced Osteogenic Gene Expression and Angiogenesis Potential in Vitro

Influence of mesenchymal stem cells with endothelial progenitor cells in co-culture on osteogenesis and angiogenesis: an in vitro study.

Enhanced Bone Tissue Regeneration of a Biomimetic Cellular Scaffold with Co-Cultured MSCs-derived Osteogenic and Angiogenic Cells

MicroRNA-200c promotes osteogenic differentiation of human bone mesenchymal stem cells through activating the AKT/β-Catenin signaling pathway via downregulating Myd88.

Small Extracellular Vesicles Derived from Hypoxic Mesenchymal Stem Cells Promote Vascularized Bone Regeneration Through the Mir-210-3p/efna3/pi3k Pathway

Exosomes derived from BMSCs in osteogenic differentiation promote type H blood vessel angiogenesis through miR-150-5p mediated metabolic reprogramming of endothelial cells

Effect of Chemically Induced Hypoxia on Osteogenic and Angiogenic Differentiation of Bone Marrow Mesenchymal Stem Cells and Human Umbilical Vein Endothelial Cells in Direct Coculture

Transcriptional Profiling Reveals Crosstalk Between Mesenchymal Stem Cells and Endothelial Cells Promoting Prevascularization by Reciprocal Mechanisms

Osteogenically Differentiated Mesenchymal Stem Cells Promote the Apoptosis of Human Umbilical Vein Endothelial Cells in Vitro